화학공학소재연구정보센터
검색결과 : 2건
No. Article
1 The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension
Chowdhury B, Luu AZ, Luu VZ, Kabir MG, Pan Y, Teoh H, Quan A, Sabongui S, Al-Omran M, Bhatt DL, Mazer CD, Connelly KA, Verma S, Hess DA
Biochemical and Biophysical Research Communications, 524(1), 50, 2020
2 Herceptin, a recombinant humanized anti-ERBB2 monoclonal antibody, induces cardiomyocyte death
Singh KK, Shukla PC, Quan A, Lovren F, Pan Y, Wolfstadt JI, Gupta M, Al-Omran M, Leong-Poi H, Teoh H, Verma S
Biochemical and Biophysical Research Communications, 411(2), 421, 2011